Latest trade
$360.9BGlobal subsector valueHS4 subsector intelligence
Blood
HS4 3002 trade overview
A focused view of this HS4 subsector: market scale, momentum, leading routes, countries, and the HS6 classifications inside it.
The numbers at a glanceLatest reported year · 2024
Annual change
+1.5%Latest year on yearExporters
191Active reporting countriesImporters
200Active reporting countriesHS6 products
8Classifications inside HS4The subsector read
$360.9B in trade, with +0.9% annualized growth over three years.
Blood is recorded across 8,364 active corridors, with 191 exporters and 200 importers.
Annual trend
Subsector momentum over time
Reported global trade from 1995 to 2024. Read the methodology ↗
Top trade corridors
Where the subsector moves
Leading exporter-to-importer relationships by latest reported value. See data sources ↗
Latest reported relationshipsTop 10 by trade value
| Rank | Exporter | Importer | Trade value | Growth | HS6 | Distance | FTA |
|---|---|---|---|---|---|---|---|
| 1 | IrelandIRL | USA, Puerto Rico and US Virgin IslandsUSA | $30.1B | +12.1% | 8 | 5,129 km | No |
| 2 | Switzerland, LiechtensteinCHE | USA, Puerto Rico and US Virgin IslandsUSA | $14.6B | +10.7% | 7 | 6,339 km | No |
| 3 | GermanyDEU | USA, Puerto Rico and US Virgin IslandsUSA | $13.9B | +9.3% | 8 | 6,402 km | No |
| 4 | SingaporeSGP | USA, Puerto Rico and US Virgin IslandsUSA | $9.2B | +50.8% | 7 | 15,347 km | Yes |
| 5 | BelgiumBEL | USA, Puerto Rico and US Virgin IslandsUSA | $9.0B | +9.4% | 8 | 5,904 km | No |
| 6 | IrelandIRL | NetherlandsNLD | $7.6B | +105.3% | 8 | 757 km | Yes |
| 7 | Switzerland, LiechtensteinCHE | GermanyDEU | $7.5B | +5.3% | 8 | 674 km | Yes |
| 8 | USA, Puerto Rico and US Virgin IslandsUSA | GermanyDEU | $7.2B | +14.2% | 8 | 6,402 km | No |
| 9 | IrelandIRL | BelgiumBEL | $5.5B | -23.4% | 7 | 776 km | Yes |
| 10 | USA, Puerto Rico and US Virgin IslandsUSA | JapanJPN | $4.2B | +7.8% | 8 | 10,872 km | No |
Market structure
Where supply and demand concentrate
Exporter and importer rankings show the two sides of the subsector separately. Check coverage ↗
| Rank | Country | Exports | Partners | HS6 |
|---|---|---|---|---|
| 1 | IrelandIRL | $62.8B | 131 | 8 |
| 2 | USA, Puerto Rico and US Virgin IslandsUSA | $51.6B | 178 | 8 |
| 3 | Switzerland, LiechtensteinCHE | $50.6B | 154 | 8 |
| 4 | GermanyDEU | $46.5B | 182 | 8 |
| 5 | BelgiumBEL | $29.4B | 184 | 8 |
| 6 | NetherlandsNLD | $15.8B | 183 | 8 |
| 7 | ItalyITA | $13.2B | 160 | 8 |
| 8 | SingaporeSGP | $11.9B | 103 | 8 |
| 9 | AustriaAUT | $10.6B | 150 | 8 |
| 10 | FranceFRA | $10.5B | 182 | 8 |
| Rank | Country | Imports | Partners | HS6 |
|---|---|---|---|---|
| 1 | USA, Puerto Rico and US Virgin IslandsUSA | $105.9B | 118 | 8 |
| 2 | GermanyDEU | $35.0B | 133 | 8 |
| 3 | NetherlandsNLD | $21.1B | 114 | 8 |
| 4 | BelgiumBEL | $16.8B | 111 | 8 |
| 5 | Switzerland, LiechtensteinCHE | $16.8B | 110 | 8 |
| 6 | ChinaCHN | $16.5B | 77 | 8 |
| 7 | ItalyITA | $12.5B | 69 | 8 |
| 8 | FranceFRA | $12.2B | 143 | 8 |
| 9 | JapanJPN | $12.2B | 68 | 8 |
| 10 | United KingdomGBR | $10.2B | 97 | 8 |
HS6 product coverage
The products inside HS4 3002
Six-digit classifications make the subsector specific. Browse the product workspace ↗
17 classifications shownBlood
Blood: human or animal, antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processesHS6 300210
Blood, human or animal, antisera, other blood fractions and immunological products: malaria diagnostic test kitsHS6 300211
Blood, human or animal, antisera, other blood fractions and immunological products: antisera and other blood fractionsHS6 300212
Blood, human or animal, antisera, other blood fractions and immunological products: immunological products, unmixed, not put up in measured doses or in forms or packings for retail saleHS6 300213
Blood, human or animal, antisera, other blood fractions and immunological products: immunological products, mixed, put up in measured doses or in forms or packings for retail saleHS6 300214
Blood, human or animal, antisera, other blood fractions and immunological products: immunological products, put up in measured doses or in forms or packings for retail saleHS6 300215
Blood, human or animal, antisera, other blood fractions and immunological products: n.e.c. in heading 3002.1HS6 300219
Vaccines: for human medicineHS6 300220
Vaccines: for veterinary medicineHS6 300230
Vaccines: for veterinary medicine, against foot and mouth diseaseHS6 300231
Vaccines: for veterinary medicine, for other uses than against foot and mouth diseaseHS6 300239
Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: for human medicineHS6 300241
Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: for veterinary medicineHS6 300242
Toxins, cultures of micro-organisms (excluding yeasts) and similar products: n.e.c. in item 3002.3HS6 300249
Cell cultures, whether or not modified: cell therapy productsHS6 300251
Cell cultures, whether or not modified: other cell cultures not including cell therapy productsHS6 300259
Toxins, cultures of micro-organisms (excluding yeasts) and similar productsHS6 300290
Definitions and coverage
Read the numbers with context
Reported observations and calculated indicators should be read with their coverage period. Responsible AI principles ↗
Reported values
Trade values describe reported merchandise trade for the HS4 classification, not company-level sales or shipment records.
Calculated indicators
Growth, concentration, volatility, and peak comparisons are calculated from reported observations.
Missing data
Unavailable observations remain unavailable. They are not filled, interpolated, or presented as forecasts.
Coverage: 1995-2024 · Data refreshed 2026-07-20 09:34:09
Data source
OECD trade statistics with CEPII context
OECD (2025), Balanced international merchandise trade statistics (BIMTS) - HS2017-6D, OECD Data Explorer (accessed on 2026-08-27). OECD BIMTS is the primary trade series for this view. Supporting bilateral trade context uses CEPII BACI bilateral trade flows (202601) under Etalab 2.0 Open Licence. Yugalinks presents derived views of reported observations and calculated indicators. Data terms: OECD Terms & Conditions.